Australian investors are poised to receive an impressive nearly $40 billion in dividends from ASX-listed companies over the next two months. With roughly $28 billion expected in September and a further $10 billion in October, this follows a robust August reporting season where two-thirds of companies increased their payouts. This windfall has propelled total dividends for the past financial year to $105.9 billion, the third-highest on record and breaking a three-year streak of declines. Experts anticipate much of this capital will be redeployed into the local market, offering a welcome boost as the ASX struggles to maintain positive territory for the year, currently up only 0.1 per cent year-to-date.
The dividend surge was largely driven by a strong performance from local miners, with companies like BHP lifting its dividend by over 50 per cent and Rio Tinto hiking its payout by 34 per cent. Lithium producers such as Mineral Resources, IGO, and PLS also reintroduced distributions. “Australian income investors have been living through a quiet dividend recession… but the August reporting season has broken the drought,” stated Plato Investment Management senior portfolio managers. Outside resources, petrol and diesel supplier Ampol saw its profit surge almost fivefold, declaring an interim dividend of $1.85 a share. Ampol is a prominent Australian company that supplies petrol and diesel. It also operates a wide network of convenience stores and provides lubricants and other fuel-related products.
Despite the dividend cheer, investor sentiment has been challenged by rising oil prices and concerns over potential Reserve Bank of Australia interest rate hikes. While Commonwealth Bank also lifted its dividend to a record $2.70 a share, some analysts caution this level may be unsustainable given growing headwinds for banks, including falling mortgage application volumes. Looking ahead, total dividends for the current financial year are projected to remain flat, which is still impressive given analysts have lowered profit forecasts. Beyond dividends, a record 23 companies announced or extended share buyback programs, including a substantial $1.1 billion buyback from CSL. CSL is a leading global biotechnology company that researches, develops, manufactures, and markets innovative biotherapies.
